Combination therapy for dendritic keratitis. High-titer alpha-interferon and trifluridine.

Abstract	Previous studies showed that the combination of trifluridine with human leukocyte interferon in the treatment of dendritic keratitis is effective, and that the best results were obtained with the highest titer then available (30 X 10(6) IU/mL). The present study was undertaken to see if an even higher titer (100 X 10(6) IU/mL) would be more effective. A statistically significant greater effectiveness of the higher titer could not be verified.
Authors	R Sundmacher, K Cantell, A Mattes
Journal	Archives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 102 Issue 4 Pg. 554-5 (Apr 1984) ISSN: 0003-9950 [Print] United States
PMID	6422914 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References	Interferon Type I Trifluridine Thymidine
Topics	Drug Therapy, Combination Humans Interferon Type I (administration & dosage) Keratitis, Dendritic (drug therapy) Thymidine (analogs & derivatives) Trifluridine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!